These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1829048)

  • 1. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo.
    Levrero M; Barban V; Manteca S; Ballay A; Balsamo C; Avantaggiati ML; Natoli G; Skellekens H; Tiollais P; Perricaudet M
    Gene; 1991 May; 101(2):195-202. PubMed ID: 1829048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
    Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
    Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.
    Morin JE; Lubeck MD; Barton JE; Conley AJ; Davis AR; Hung PP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4626-30. PubMed ID: 2955413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
    Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
    Amalfitano A; Begy CR; Chamberlain JS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
    Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
    Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses.
    Ballay A; Levrero M; Buendia MA; Tiollais P; Perricaudet M
    EMBO J; 1985 Dec; 4(13B):3861-5. PubMed ID: 3004975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
    Chengalvala MV; Bhat BM; Bhat RA; Dheer SK; Lubeck MD; Purcell RH; Murthy KK
    Vaccine; 1997 Feb; 15(3):335-9. PubMed ID: 9139496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
    Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.
    Eloit M; Adam M; Gallais I; Fournier A
    J Virol; 1997 Jul; 71(7):5375-81. PubMed ID: 9188608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.
    Chanda PK; Natuk RJ; Dheer SK; Lubeck MD; Bhat BM; Mason BB; Greenberg L; Mizutani S; Davis AR; Hung PP
    Int Rev Immunol; 1990; 7(1):67-77. PubMed ID: 2132880
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of an adenovirus type 7a E1A- vector.
    Abrahamsen K; Kong HL; Mastrangeli A; Brough D; Lizonova A; Crystal RG; Falck-Pedersen E
    J Virol; 1997 Nov; 71(11):8946-51. PubMed ID: 9343264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation.
    Avvakumov N; Mymryk JS
    J Virol Methods; 2002 May; 103(1):41-9. PubMed ID: 11906731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
    Eissa NT; Chu CS; Danel C; Crystal RG
    Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.
    Fernholz D; Galle PR; Stemler M; Brunetto M; Bonino F; Will H
    Virology; 1993 May; 194(1):137-48. PubMed ID: 8480417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc.
    Xu ZZ; Krougliak V; Prevec L; Graham FL; Both GW
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1971-80. PubMed ID: 7636477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells.
    Goldsmith KT; Curiel DT; Engler JA; Garver RI
    Hum Gene Ther; 1994 Nov; 5(11):1341-8. PubMed ID: 7893805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.